These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 25688888)

  • 41. Radiofrequency ablation versus surgical resection for multiple HCCs meeting the Milan criteria: propensity score analyses of 10-year therapeutic outcomes.
    Min JH; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Sinn DH; Kim JM; Sohn I
    Clin Radiol; 2018 Jul; 73(7):676.e15-676.e24. PubMed ID: 29709236
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Resection versus ablation in hepatitis B virus-related hepatocellular carcinoma patients with portal hypertension: A propensity score matching study.
    Qiu J; Zheng Y; Shen J; Zeng QA; Zou R; Liao Y; He W; Li Q; Chen G; Li B; Yuan Y
    Surgery; 2015 Nov; 158(5):1235-43. PubMed ID: 25958066
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prospective study of a 'popping' sound during percutaneous radiofrequency ablation for hepatocellular carcinoma.
    Fernandes ML; Lin CC; Lin CJ; Chen WT; Lin SM
    J Vasc Interv Radiol; 2010 Feb; 21(2):237-44. PubMed ID: 20031448
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Laparoscopic ablation therapies or hepatic resection in cirrhotic patients with small hepatocellular carcinoma.
    Santambrogio R; Bruno S; Kluger MD; Costa M; Salceda J; Belli A; Laurent A; Barabino M; Opocher E; Azoulay D; Cherqui D
    Dig Liver Dis; 2016 Feb; 48(2):189-96. PubMed ID: 26675381
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy.
    Yamakado K; Nakatsuka A; Takaki H; Yokoi H; Usui M; Sakurai H; Isaji S; Shiraki K; Fuke H; Uemoto S; Takeda K
    Radiology; 2008 Apr; 247(1):260-6. PubMed ID: 18305190
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Percutaneous radiofrequency ablation of hepatocellular carcinoma: effect of histologic grade on therapeutic results.
    Kim SH; Lim HK; Choi D; Lee WJ; Kim SH; Kim MJ; Kim CK; Jeon YH; Lee JM; Rhim H
    AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S327-33. PubMed ID: 16632696
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiofrequency ablation: technical and clinical long-term outcomes for single hepatocellular carcinoma up to 30 mm.
    Brunello F; Cantamessa A; Gaia S; Carucci P; Rolle E; Castiglione A; Ciccone G; Rizzetto M
    Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):842-9. PubMed ID: 23442417
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intraoperative radiofrequency ablation for hepatocellular carcinoma: long-term results in a large series.
    Kim YS; Rhim H; Lim HK; Choi D; Lee WJ; Jeon TY; Joh JW; Kim SJ
    Ann Surg Oncol; 2008 Jul; 15(7):1862-70. PubMed ID: 18463926
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combined resection with radiofrequency ablation for bilobar hepatocellular carcinoma: a single-center experience.
    Zhang T; Zeng Y; Huang J; Liao M; Wu H
    J Surg Res; 2014 Oct; 191(2):370-8. PubMed ID: 24766727
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transarterial chemoembolization using drug eluting beads and subsequent percutaneous MR-guided radiofrequency ablation in the therapy of intermediate sized hepatocellular carcinoma.
    Hoffmann R; Rempp H; Syha R; Ketelsen D; Pereira PL; Claussen CD; Clasen S
    Eur J Radiol; 2014 Oct; 83(10):1793-8. PubMed ID: 25052871
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radiofrequency ablation versus radical nephrectomy: clinical outcomes for stage T1b renal cell carcinoma.
    Takaki H; Soga N; Kanda H; Nakatsuka A; Uraki J; Fujimori M; Yamanaka T; Hasegawa T; Arima K; Sugimura Y; Sakuma H; Yamakado K
    Radiology; 2014 Jan; 270(1):292-9. PubMed ID: 23925272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. RF Ablation Versus Cryoablation for Small Perivascular Hepatocellular Carcinoma: Propensity Score Analyses of Mid-Term Outcomes.
    Cha SY; Kang TW; Min JH; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Park MS
    Cardiovasc Intervent Radiol; 2020 Mar; 43(3):434-444. PubMed ID: 31844951
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term outcomes after hepatectomy for recurrences after prior local ablation for hepatocellular carcinoma.
    Sakata J; Shirai Y; Wakai T; Kaneko K; Hatakeyama K
    Eur J Surg Oncol; 2008 Apr; 34(4):433-8. PubMed ID: 17475439
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis.
    N'Kontchou G; Mahamoudi A; Aout M; Ganne-Carrié N; Grando V; Coderc E; Vicaut E; Trinchet JC; Sellier N; Beaugrand M; Seror O
    Hepatology; 2009 Nov; 50(5):1475-83. PubMed ID: 19731239
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatocellular carcinoma invading portal venous system in cirrhosis: long-term results of percutaneous radiofrequency ablation of both the nodule and portal vein tumor thrombus. A case control study.
    Giorgio A; Calisti G; Montesarchio L; Scognamiglio U; Matteucci P; Coppola C; Scarano F; Amendola F; Giorgio V
    Anticancer Res; 2014 Nov; 34(11):6785-90. PubMed ID: 25368292
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-powered microwave ablation of larger hepatocellular carcinoma: evaluation of recurrence rate and factors related to recurrence.
    Zhang NN; Lu W; Cheng XJ; Liu JY; Zhou YH; Li F
    Clin Radiol; 2015 Nov; 70(11):1237-43. PubMed ID: 26220125
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Subcapsular liver tumors treated with percutaneous radiofrequency ablation: a prospective comparison with nonsubcapsular liver tumors for safety and effectiveness.
    Sartori S; Tombesi P; Macario F; Nielsen I; Tassinari D; Catellani M; Abbasciano V
    Radiology; 2008 Aug; 248(2):670-9. PubMed ID: 18519740
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microwave versus Radiofrequency Ablation Treatment for Hepatocellular Carcinoma: A Comparison of Efficacy at a Single Center.
    Potretzke TA; Ziemlewicz TJ; Hinshaw JL; Lubner MG; Wells SA; Brace CL; Agarwal P; Lee FT
    J Vasc Interv Radiol; 2016 May; 27(5):631-8. PubMed ID: 27017124
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
    Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
    Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.